TCL Archive NCI Director Broder’s Year In Review: Avoid Politics, Stay Focused On Science October 28, 1994
TCL Archive NCAB Agrees With NCI Recommendation To Drop PO1 Chartered Committees, Adopt Single Review February 13, 1987
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
